FMI Analyzes Impact of COVID-19 on Connected Drug Delivery Devices Market ; Stakeholders to Focus on Long-term Dimensions
Global Healthcare Sector Outlook in Light of the Global Connected Drug Delivery Devices Market
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.
Request Sample Copy of this Report @
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.
Parent Indicators Healthcare
- Current expenditure on health, % of gross domestic product
- Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
- Annual growth rate of current expenditure on health, per capita, in real terms
- Out-of-pocket expenditure, % of current expenditure on health
- Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
- Physicians, Density per 1000 population (head counts)
- Nurses, Density per 1000 population (head counts)
- Total hospital beds, per 1000 population
- Curative (acute) care beds, per 1000 population
- Medical technology, Magnetic Resonance Imaging units, total, per million population
- Medical technology, Computed Tomography scanners, total, per million population
FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market estimations and insights on various medical devices and medical technology. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.
Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product offerings, usage pattern as per disease indications, product installed base in target healthcare facilities, life span of a device, reimbursement scenario, adoption rate and future impact of new technologies.
Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.
Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, and supply-side providers of medical devices who provide valuable insights on trends, key treatment patterns, adoption rate, and purchasing pattern, technological development of medical devices, patient education, effectiveness of manufacturers and important strategies, pricing and competitive dynamics.
Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.
Ask An Analyst :
On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at tier level based on their revenues, product portfolio and presence.
Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.
Standard Report Structure
- Executive Summary
- Market Definition
- Macro-economic analysis
- Parent Market Analysis
- Market Overview
- Forecast Factors
- Segmental Analysis and Forecast
- Regional Analysis
- Competition Analysis
The global connected drug delivery devices market has been segmented into:RegionEnd UserProduct TypeTechnologyApplication
|North AmericaLatin AmericaWestern EuropeEastern EuropeAPECJChinaJapanMEA||HospitalsClinicsHome Care||Inhalation DevicesInjectable DevicesHandheld Injectable DevicesWearable Injectable Devices||BluetoothNear Field Communication||AnaphylaxisCardiovascularDiabetesHormone ReplacementOthers|